During the 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020) scheduled to take place in Madrid, Spain, 19-22 February 2020, Adocia is pleased to present the E-Poster: “ADO09, A CO-FORMULATION OF THE AMYLIN-ANALOG PRAMLINTIDE AND THE A21G HUMAN INSULIN ANALOG, LOWERS POSTPRANDIAL BLOOD GLUCOSE VERSUS INSULIN LISPRO IN TYPE 1 DIABETES (T1D)”
To discover the E-Poster: E-Posters will be available at the E-Poster stations at the Conference, on the ATTD 2020 website during the Conference and additionally in an online archive for one year following the Conference.
Venue: IFEMA Palacio MunicipalCampo de las Naciones
Avda. Capital de España Madrid
7-28042 – Madrid – Spain
Please, see tha Adocia Abstract detail